[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594215":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":15,"locations":25,"responsibleParty":43,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"University Hospital, Rouen","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Patient having experienced at least one venous thromboembolic episode",null,[12],{"name":13,"affiliation":5,"role":14},"Sébastien SM MIRANDA, Doctor","PRINCIPAL_INVESTIGATOR",[16,22],{"name":17,"role":18,"phone":19,"phoneExt":20,"email":21},"David DM MALLET, Director","CONTACT","02 32 88 82 65","+33","David.Mallet@chu-rouen.fr",{"name":23,"role":18,"phone":19,"phoneExt":20,"email":24},"Vincent VF FERRANTI, ARC","Vincent.Ferranti@chu-rouen.fr",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"University Hospital of Rouen","RECRUITING","Rouen","76031","France","FR",{"type":34,"coordinates":35},"Point",[36,37],1.09932,49.44313,{"lat":37,"lon":36},[40],{"name":13,"role":18,"phone":41,"phoneExt":20,"email":42},"02 32 88 90 01","Sebastien.Miranda@chu-rouen.fr",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100594215","cohort-for-monitoring-patients-with-venous-thromboembolic-disease-100594215",false,"NCT07016542","Cohort for Monitoring Patients With Venous Thromboembolic Disease","CoMTEV","Inclusion Criteria:\n\n1. Any patient over 18 years of age who has experienced at least one venous thromboembolic episode:\n\n   * Deep vein thrombosis confirmed by Doppler ultrasound or CT venography,\n   * Pulmonary embolism confirmed by CT angiography, ventilation\u002Fperfusion scan, or confirmed DVT episode with respiratory signs consistent with PE.\n2. Hospitalization in the Internal Medicine Department\n3. Consultation by an Internal Medicine physician\n4. File presented at the thrombosis multidisciplinary meeting\n\nExclusion Criteria:\n\nThrombosis not meeting the inclusion criteria (cerebral venous thrombosis, mesenteric)","ALL","18 Years",{"count":55,"type":56},2000,"ESTIMATED","12 Years","OBSERVATIONAL","Venous thromboembolic disease is a common pathology in the general population (1.5\u002F1000), the prognosis of which depends in particular on the risk of recurrence. This risk depends essentially on whether the thrombotic episode was provoked or not. Thus, patients who present a thromboembolic event without any contributing factor have a high risk of recurrence, which encourages clinicians to continue anticoagulant treatment for a long time. However, anticoagulant treatment is the leading cause of hospitalization for iatrogenic causes and the leading cause of iatrogenic mortality. The benefit-risk balance of treatment must be evaluated regularly, which requires a good knowledge of the risk factors for thrombotic recurrence and the risk factors for hemorrhage.",[61],"Venous Thromboembolic Disease",[63,64],"risk of thrombotic recurrence","hemorrhagic risk factors","2025-06-04",{"date":67,"type":68},"2025-06-11","ACTUAL",{"date":70,"type":68},"2019-11-18",{"date":72,"type":56},"2032-06-01",{"name":5,"class":6},1]